These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 426317

  • 1. Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease.
    Di Perri T, Forconi S, Guerrini M, Pasini FL, Del Cippola R, Rossi C, Angnusdei D.
    Angiology; 1979 Jan; 30(1):13-20. PubMed ID: 426317
    [Abstract] [Full Text] [Related]

  • 2. Action of cinnarizine on the blood flow of the lower limbs in patients affected by obliterative peripheral arterial disease and in normal subjects.
    Forconi S, Guerrini M, Di Perri T.
    Vasa; 1976 Jan; 5(4):360-5. PubMed ID: 1007545
    [No Abstract] [Full Text] [Related]

  • 3. The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease.
    Di Perri T, Forconi S, Agnusdei D, Guerrini M, Laghi Pasini F.
    Br J Clin Pharmacol; 1978 Mar; 5(3):255-60. PubMed ID: 656271
    [Abstract] [Full Text] [Related]

  • 4. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease.
    Vigilance JE, Reid HL.
    J Diabetes Complications; 2008 Mar; 22(3):210-6. PubMed ID: 18413225
    [Abstract] [Full Text] [Related]

  • 5. Arterial and venous blood viscosity in ischemic lower limbs in patients affected by peripheral obliterative arterial disease.
    Forconi S, Guerrini M, Ravelli P, Rossi C, Ferrozzi C, Pecchi S, Biasi G.
    J Cardiovasc Surg (Torino); 1979 Mar; 20(4):379-84. PubMed ID: 479273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions.
    De Cree J, De Cock W, Geukens H, De Clerck F, Beerens M, Verhaegen H.
    Angiology; 1979 Aug; 30(8):505-15. PubMed ID: 380411
    [No Abstract] [Full Text] [Related]

  • 9. Erythrocyte deformability in peripheral occlusive arterial disease.
    Bareford D, Lucas GS, Caldwell NM, Stone PC, Baar S, Stuart J.
    J Clin Pathol; 1985 Feb; 38(2):135-9. PubMed ID: 2857183
    [Abstract] [Full Text] [Related]

  • 10. [Cellular rheology in obliterative arterial diseases of the lower limbs].
    Lombardini R, Ciuffetti G, Palazzetti D, Mannarino E, Pasqualini L, Scarponi AM, Mercuri M, Siepi D.
    Ric Clin Lab; 1989 Feb; 19 Suppl 1():91-3. PubMed ID: 2629095
    [No Abstract] [Full Text] [Related]

  • 11. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease.
    Giunta R, Coppola A, Luongo C, Sammartino A, Guastafierro S, Grassia A, Giunta L, Mascolo L, Tirelli A, Coppola L.
    Ann Hematol; 2001 Dec; 80(12):745-8. PubMed ID: 11797116
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease.
    Gaddi A, Galetti C, Illuminati B, Nascetti S.
    J Int Med Res; 1996 Dec; 24(5):389-406. PubMed ID: 8895043
    [Abstract] [Full Text] [Related]

  • 13. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
    Artale F, Sergio G, Cramarossa L, Giunti P, Francisci A, Perego MA.
    Ric Clin Lab; 1983 Dec; 13 Suppl 3():411-5. PubMed ID: 6673022
    [Abstract] [Full Text] [Related]

  • 14. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Dec; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 15. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R, Hänsgen K, Podhaisky H.
    Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
    [Abstract] [Full Text] [Related]

  • 16. Allopurinol prevents ischaemia-dependent haemorheological changes.
    Capecchi PL, Pasini FL, Pasqui AL, Orrico A, Ceccatelli L, Acciavatti A, Galigani C, Pieragalli D, Di Perri T.
    Eur J Clin Pharmacol; 1988 Nov; 35(5):475-81. PubMed ID: 2853054
    [Abstract] [Full Text] [Related]

  • 17. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM.
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [Abstract] [Full Text] [Related]

  • 18. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
    Chmiel H, Anadere I, Heimburg P.
    Ric Clin Lab; 1981 Mar; 11 Suppl 1():189-96. PubMed ID: 7188108
    [Abstract] [Full Text] [Related]

  • 19. [Hemorrheological changes in peripheral obliterative arterial diseases].
    Bartoli V, Albanese B, Morini R, Pasquini G, Manescalchi PG.
    Ric Clin Lab; 1983 Mar; 13 Suppl 3():209-18. PubMed ID: 6672997
    [Abstract] [Full Text] [Related]

  • 20. [The effect of lysine acetylsalicylate on hemorrheological changes induced through ischemic exertion in patients with vascular disease].
    Vittoria A, Guerrini M, Pieragalli D, Del Bigo C, Martelli G, Franchi M, Messa G, Blardi P, Galigani C, Di Perri T.
    Ric Clin Lab; 1983 Mar; 13 Suppl 3():315-21. PubMed ID: 6231713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.